BIOVECTRA

A global, full-service CDMO specializing in biologics, small molecules, pDNA/mRNA manufacturing, HPAPIs, & bioreagents.

[BIOVECTRA @BioVectra]

One week until the JP Morgan Healthcare Conference! Meet BIOVECTRA to discuss biologics, mRNA, and LNP solutions. Request a meeting: https://t.co/nvFXYcNgW9

[BIOVECTRA @BioVectra]

Attending Advanced Therapies Week? Let's connect! BIOVECTRA offers solutions for mRNA, pDNA, and more. Schedule a meeting: https://t.co/DpF8q1O6Dw #AdvancedTherapiesWeek #CDMO #GeneTherapy #CellTherapy #Biomanufacturing #PharmaInnovation #mRNA

[BIOVECTRA @BioVectra]

Join us at #MeetingOnTheMesa to discover how our #CDMO solutions can streamline mRNA & biologics manufacturing. From overcoming supply chain challenges to accelerating scale-up, we’re here to help. Schedule a meeting!
https://t.co/7zJksu6ycr
#mRNATherapeutics #Biomanufacturing

[BIOVECTRA @BioVectra]

@Agilent has signed an agreement to acquire @BioVectra creating new opportunities to improve patient care by expanding the range of capabilities available to our global pharmaceutical partners.
News Release: https://t.co/WshTmewv47
Customer Information: https://t.co/DNoYpl6olV

[BIOVECTRA @BioVectra]

We still have 2 full days of BIO International ahead of us! Swing by Booth 5545 and chat with us about your projects — we can’t wait to meet you!

#BIO2024 #cdmo #HPAPIs #biologics #pDNA #mRNA
#fermentation #syntheticsmallmolecules #bioreagents #MPEGs #complexchemistry

[BIOVECTRA @BioVectra]

We’re here in San Diego for BIO 2024! Come find us on the show floor (Booth 5545) and say hello! 👋🏻We’d love to meet with you!
#BIO2024 #cdmo #HPAPIs #biologics #pDNA #mRNA

[BIOVECTRA @BioVectra]

Contract Pharma recently interviewed Marc Sauer about what BIOVECTRA has been up to the past several months, including our new biomanufacturing facility in Charlottetown, PE, and our partnership with Acuitas Therapeutics. Read the full interview here: https://t.co/DMaYwlzOTa

[BIOVECTRA @BioVectra]

We are thrilled to be named a #ACTopEmployers again because of our support for our employees’ mental health, their career development, and for our excellent maternity and parental leave benefits! Congratulations all! https://t.co/HN1g7zI7ST
#ACTopEmployers #topemployers2024

[BIOVECTRA @BioVectra]

Read our newest article, authored by Jean-François Vincent-Rocan & published in Pharma's Almanac, to learn more about synthetic chemistry has key role in enabling us to offer reliable, efficient, & cost-effective solutions to our clients today. https://t.co/fAweZ102xZ

[BIOVECTRA @BioVectra]

Since the pandemic, there has been renewed interest in exploring time-to-market for various therapeutics. In this new article featuring BIOVECTRA’s Peter Ercoli, experts explore how the process can be accelerated without compromising quality.

https://t.co/uqBtal4Sed

[BIOVECTRA @BioVectra]

In this webinar, we'll dive into ADC manufacturing and the recommended strategies to overcome common potency testing and product purity challenges, as well as share insights into the advantages of utilizing cGMP grade DHAA and TCEP in ADC manufacturing

https://t.co/G3oQJ73jvE

[BIOVECTRA @BioVectra]

Discover how BIOVECTRA can best support your upcoming biologics and complex chemistry projects at next week's BOS Manchester. With 50+ years of pharmaceutical manufacturing experience, we can deliver you solutions quickly and efficiently. https://t.co/UEQkIsf9cc

[BIOVECTRA @BioVectra]

[Webinar Alert] Join Jessica Madigan to gain insights into commercial manufacturing in mRNA clinical therapies, as well as the challenges and inventive solutions to be aware of for development, scaling and commercialization. https://t.co/xReENb0yBT

[BIOVECTRA @BioVectra]

@USAmbCanada It was our pleasure hosting you Ambassador Cohen. Thank you for your keen interest today. Enjoy the rest of your visit to #pei!

[BIOVECTRA @BioVectra]

As a manufacturer of both small molecules and biologics, BIOVECTRA is ideally positioned to support clients developing #mRNA vaccines and therapeutics.

Check out the latest in Pharma's Almanac to learn about our fit-for-purpose manufacturing solutions: https://t.co/hJat9QpIjI

[BIOVECTRA @BioVectra]

BIOVECTRA Signs Service Agreement with Acuitas Therapeutics for Unique Lipid Nanoparticle Delivery System Used in Manufacturing mRNA-Based Therapies

Learn more: https://t.co/kMsEHoV2fQ

[BIOVECTRA @BioVectra]

At BIOVECTRA, microbial fermentation is core to much of what we do so we're thrilled - but not surprised - to see two of our own featured in BioPharm International's piece, "Optimizing Fermentation Processes for Biologics Manufacturing." Check it out! https://t.co/GTOyvsimfp

[CASTL @CastlCanada]

CASTL trainers had the pleasure of touring the progress of the new @BioVectra pDNA and mRNA manufacturing facility in preparation for our upcoming customized training.

Learn more about the project: https://t.co/1zzSG13I07 #PEI

[BIOVECTRA @BioVectra]

📢 We’re heading to Boston for BPI East 2023!

Find us at booth 557 and learn how we can support your upcoming biologics, complex chemistry, and DNA/RNA projects.

Reach out to pre-schedule a meeting and see how we can help! https://t.co/LqXB10O69t

#BPIEast2023 #BioPharma #CDMO

[BIOVECTRA @BioVectra]

We’re 2 months away from #CPHI Barcelona and can’t wait to connect with YOU! Stop by stand E11 3H20 and learn how our experienced team can help with your most complex drug substance and manufacturing needs.

Schedule time with us! https://t.co/0Z6iIwAP4E

#CPHIBarcelona #CDMO